This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hercules Technology Growth Capital Announces Strong New Commitments In Quarter-to-Date Q4 2012 And Provides Year-to-Date 2012 Portfolio Update

Hercules Technology Growth Capital, Inc. (NYSE: HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science and cleantech industries, at all stages of development, today announced its quarter-to-date fourth quarter 2012 portfolio update.

“2012 has been a tremendous year for Hercules in which we executed across all areas of our business and clearly established the company as the undisputed business development company (BDC) leader in venture lending,” said Manuel A. Henriquez, Hercules co-founder, chairman and chief executive officer. “2012 was marked with numerous first-time achievements, ranging from completing our first Moody’s-rated A2 (sf) securitization of $231.0 million with net proceeds of approximately $129.0 million, to completing three senior unsecured and unrated 7.0% seven-year bond offerings or our first ‘baby bond’ capital raises totaling approximately $170.0 million, to executing two equity capital raises totaling approximately $81.0 million, all while achieving portfolio and earnings growth for our investors. We are very pleased that the financial community continues to recognize the quality of our portfolio, the caliber of our team, and our ability to identify investment opportunites, which is all underscored by Moody’s A2 (sf) rating of our securitization.”

Henriquez continued, “Despite a turbulent and unpredictable market triggered by post U.S. election uncertainty, the continued Euro crisis and now the looming fiscal cliff, we continued to meet the strong demand for venture lending from entrepreneurial companies during the fourth quarter. However, as has been the case through most of 2012, many of these commitments closed near the end of the quarter. We do not expect the majority of the new fundings to have a meaningful impact on our fourth quarter financial results given the late close, but they should provide for a strong start to 2013.”

Q4 Quarter-to-Date Originations:

As of December 19, 2012, Hercules has originated approximately $205.0 million of debt and equity commitments to new and existing portfolio companies.

Hercules' new investment commitments include:
  • $40.0 million to Merrimack Pharmaceuticals (NASDAQ: MACK), a biopharmaceutical company with an initial focus on cancer that is engaged in discovering, developing and preparing to commercialize innovative medicines that are paired with companion diagnostics for the treatment of serious diseases.
  • $34.0 million commitment to Comverge, Inc., the leading provider of Intelligent Energy Management solutions for Residential and Commercial & Industrial (C&I) customers.
  • $15.0 million commitment to ShareThis, the largest platform for sharing and influence across the web, reaching more than 600 million users across more than two million websites.
  • $14.5 million commitment to, an online media platform that delivers women-focused content to its 20 million viewers.
  • $10.0 million commitment to Redwood Systems, the leading provider of building-performance lighting solutions.
  • $10.0 million commitment to Identive Group (NASDAQ: INVE; Frankfurt: INV), a provider of solutions and services for the identification, security and RFID industries.
  • $8.5 million commitment to NuPathe, Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders.
  • $6.0 million commitment to Polyera, a leading supplier of advanced semiconductor materials for the electronics industry including flat panel displays.
  • $1.0 million commitment to Clustrix, the scale-out SQL database for Big Data applications.

In addition, Hercules provided more than $65.0 million in new commitments and renewals to existing portfolio companies.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs